<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This study aimed to investigate the expression of PEBP4 protein in colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> tissues and its correlation with the clinical pathology of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and to investigate the relationship between PEBP4 expression and the invasion and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells, which could provide an experimental basis for future biological treatments of human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>RT-PCR and western blot methods were applied to detect the <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein expressions, respectively, of PEBP4 in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> tissues and <z:mpath ids='MPATH_458'>normal</z:mpath> pericarcinoma tissues, and their correlations with the <z:mp ids='MP_0002006'>tumorigenesis</z:mp> and development of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, as well as its clinical pathology, were analyzed </plain></SENT>
<SENT sid="2" pm="."><plain>Using the <z:chebi fb="40" ids="33697">RNA</z:chebi> interference technology, the expression of PEBP4 was knocked down in the human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell HCT116, and the changes of the invasion capability of HCT116 were monitored </plain></SENT>
<SENT sid="3" pm="."><plain>The positive <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression rate of PEBP4 in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> tissue was significantly higher than that in the <z:mpath ids='MPATH_458'>normal</z:mpath> pericarcinoma tissue (p &lt; 0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>Also, the positive expression rate in the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissues from patients with positive lymph node and distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> was significantly higher than that from the patients negative for lymph node and distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (p &lt; 0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>The positive expression rate of PEBP4 in the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissues from the patients in early stages (I, II) was significantly lower than the expression rate in patients in advanced stages (III, IV) (p &lt; 0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>A lower degree of differentiation in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> corresponded to a higher positive <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression rate of PEBP4 (p &lt; 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>However, this was independent of the patient's gender, age, and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size (p &gt; 0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>In <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> tissue, the expression of PEBP4 protein was consistent with its <z:chebi fb="2" ids="33699">mRNA</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>Namely, PEBP4 protein expression in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> tissues was significantly higher than that in the <z:mpath ids='MPATH_458'>normal</z:mpath> pericarcinoma tissues (p &lt; 0.05), the expression in the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissues from the patients with positive lymph node and distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> was significantly higher than that from the patients who were negative for these <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> (p &lt; 0.05), and a lower degree of differentiation in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> corresponded to a higher TNM staging along with a higher PEBP4 protein expression (p &lt; 0.05) </plain></SENT>
<SENT sid="10" pm="."><plain>After HCT116 cells transfected with PEBP4 siRNA, they showed a significantly lower expression level of PEBP4 protein (p &lt; 0.05), and the number of cells that passed through the Transwell chamber was significantly lower compared to the non-transfected or the transfected controls (p &lt; 0.05) </plain></SENT>
<SENT sid="11" pm="."><plain>The over-expression of PEBP4 protein may be related to the <z:mp ids='MP_0002006'>tumorigenesis</z:mp>, development, <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, and invasion of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>